InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.72
(
-0.22%
)
Bitcoin
57,349.87
(
-4.68%
)
Post# of 252478
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: DewDiligence post# 197838

Tuesday, 12/01/2015 12:44:59 PM

Tuesday, December 01, 2015 12:44:59 PM

Post# of 252478
" currently treated patients are receiving a different vector from what earlier patients received, so BLUE is already on at least its second iteration of LentiGlobin."
As per my previous message what I mean is that there is a continuous improvement and I don't see that as a negative thing but the normal in R&D
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up